Pharma Industry News

U.S. Food and Drug Administration Approves ABILIFY? (aripiprazole) for the Treatment of Irritability Associated with Autistic Disorder in Pediatric Patients (Ages 6 to 17 Years)

Bristol-Myers Squibb Gets FDA Approval To Market Abilify For Treatment Of Irritability Associated With Autistic Disorder - Quick Facts

PRINCETON, NJ, Nov. 20 /PRNewswire-FirstCall/ - NUCRYST Pharmaceuticals Corp. announced today that a Special Meeting of Shareholders will be held on Monday, December 21, 2009. The purpose of the Meeting is to consider approval of two special resolutions.

Pfizer Must Pay $6.3 Million in Damages Over Prempro

Bloomberg - 1 hour ago
By Sophia Pearson and Jef Feeley Nov. 20 (Bloomberg) -- Two Pfizer Inc. units' hormone- replacement therapy drugs Prempro and Provera caused an Illinois woman's breast cancer, making them liable ...

Direction Of Health Overhaul Helps US Drug Stocks >MRK PFE

Wall Street Journal - 50 minutes ago
By Peter Loftus Of DOW JONES NEWSWIRES Several US pharmaceutical stocks rose Friday as Pfizer Inc. (PFE) and Merck & Co. (MRK) hit 52-week highs, partly due to increasing investor comfort that a ...

LOUISVILLE, Ky., Nov. 20 /PRNewswire/ -- The National Association of Drug Diversion Investigators (NADDI) today announced a new initiative in the war on methamphetamine. The National Precursor Log Exchange (NPLEx) is a multi-state electronic tracking program that enforces purchase limitations on over-the-counter (OTC) medicines containing pseudoephedrine in real-time at the point of sale.

Teva Receives Final Approval For Generic

Ethio Planet News - 52 minutes ago
Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the US Food and Drug Administration has granted final approval for the Company's Abbreviated New Drug Application (ANDA) to ...

HAIFA, Israel, November 20 /PRNewswire-FirstCall/ -- Cardio Vascular
Medical Device Corp.

MINNEAPOLIS, Nov. 20 /PRNewswire/ -- Medtronic, Inc. today announced the kick-off of an educational campaign aimed at raising awareness among women of overactive bladder (OAB), a serious condition that can severely impact patients' lives.

Pfizer Units Must Pay $6.3 Million in Prempro Case

Bloomberg - 12 minutes ago
By Sophia Pearson and Jef Feeley Nov. 20 (Bloomberg) -- Two Pfizer Inc. units' hormone- replacement therapy drugs Prempro and Provera caused an Illinois woman's breast cancer and are liable for at ...